Brooks Laboratories Limited (BROOKS.NS) NSE
64.42
-2.63(-3.92%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.09B |
| Enterprise Value | 1.1B |
| P/E Ratio | 7.79 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 2.25 |
| Price/Book Ratio | 1.56 |
| Enterprise/Revenue | 2.26 |
| Enterprise/EBITDA | 9.46 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.29 |
| Operating Margin | 0.06 |
Management Effectiveness
| Return On Assets | 0.17 |
| Return On Equity | 0.23 |
Income Statement
| Revenue | 857.38M |
| Revenue/Share | 29.27 |
| Gross Profit | 179.65M |
| EBITDA | 70.6M |
| Net Income | 245.84M |
| Diluted EPS | 8.35 |
Balance Sheet
| Total Cash | 75.49M |
| Total Cash/Share | 2.58 |
| Total Debt | 85.17M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 1.72 |
| Book Value Per Share | 41.88 |
Price History
| 52-Week Change | -56.07 |
| 52-Week High | 164.02 |
| 52-Week Low | 36.3 |
| Moving Average 50 Days | 56.84 |
| Moving Average 200 Days | 89.45 |
Statistics
| Average Volume | 145,426 |
| Shares Outstanding | 29.46M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1199:1000 |
| Last Split Date | February 11, 2020 |
